The preliminary results of a clinical trial suggest a new treatment for Covid-19 dramatically reduces the number of patients needing intensive care, according to the UK company that developed it.The treatment from Southampton-based biotech Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection. The protein is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune response.The initial findings suggest the treatment cut the odds of a Covid-19 patient in hospital developing severe disease - such as requiring ventilation - by 79%.Coronavirus: Protein treatment trial 'a breakthrough'Interesting read 9 Likes
toomuchbaloney Jul 20, 2020 We certainly need this since a percentage of Americans seem intent upon causing as many infections as possible through ignorant and selfish behavior. 6 Likes
herring_RN, ASN, BSN Specializes in Critical care, tele, Medical-Surgical. Has 49 years experience. Jul 20, 2020 Scientists and physicians have discovered treatments that help more people survive COVID-19. I continue praying for a vaccine and/or long term treatment like they did for HIV. 5 Likes
Kitiger, RN Specializes in Private Duty Pediatrics. Has 42 years experience. Jul 20, 2020 And here is yet one more reason for me to social distance, mask up, etc., now. If I have to get COVID, I want to get it later, when we know more and have better treatments. This certainly looks hopeful. 5 Likes
sevensonnets Jul 20, 2020 I've considering raising llamas for the antibodies but there's no room for them on my front porch. Scared they might eat my veggies. I think I'll wait for this one instead! 2 Likes
Kooky Korky, BSN, RN Jul 22, 2020 This is fabulous news! Let's hope there is more good news very soon. 3 Likes
